Celldex Therapeutics, Inc.

CLDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 16, 2017 FORM 4 -
3 Jun 16, 2017 OWNERSHIP DOCUMENT
3 Jun 16, 2017 OWNERSHIP DOCUMENT
8-K Jun 16, 2017 8-K
4 Jun 1, 2017 FORM 4 -
SC 13G/A May 10, 2017
10-Q May 9, 2017 10-Q
8-K May 9, 2017 FORM 8-K
4 May 1, 2017 FORM 4 -
DEF 14A Apr 28, 2017 DEF 14A
PRE 14A Apr 17, 2017 PRE 14A
4 Apr 3, 2017 FORM 4 -
10-K Mar 14, 2017 10-K
8-K Mar 14, 2017 FORM 8-K
4 Mar 3, 2017 FORM 4 -
4 Mar 1, 2017 FORM 4 -
3 Mar 1, 2017 OWNERSHIP DOCUMENT
8-K Mar 1, 2017 8-K
424B3 Feb 14, 2017 424B3
424B3 Feb 14, 2017 424B3
SC 13G/A Feb 14, 2017 SCHEDULE 13G
SC 13G/A Feb 14, 2017
EFFECT Feb 13, 2017
EFFECT Feb 13, 2017
SC 13G Feb 10, 2017 SC 13G
← Newer Page 21 of 49 · 1222 filings Older →